HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease

The WAVE regulatory complex (WRC) is a multiunit complex that regulates actin cytoskeleton formation. Although other actin-regulatory proteins modulate human immune responses, the precise role for the WRC has not yet been established. Cook et al. studied five patients from four unrelated families wh...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 369; no. 6500; pp. 202 - 207
Main Authors Cook, Sarah A., Comrie, William A., Poli, M. Cecilia, Similuk, Morgan, Oler, Andrew J., Faruqi, Aiman J., Kuhns, Douglas B., Yang, Sheng, Vargas-Hernández, Alexander, Carisey, Alexandre F., Fournier, Benjamin, Anderson, D. Eric, Price, Susan, Smelkinson, Margery, Abou Chahla, Wadih, Forbes, Lisa R., Mace, Emily M., Cao, Tram N., Coban-Akdemir, Zeynep H., Jhangiani, Shalini N., Muzny, Donna M., Gibbs, Richard A., Lupski, James R., Orange, Jordan S., Cuvelier, Geoffrey D. E., Al Hassani, Moza, Al Kaabi, Nawal, Al Yafei, Zain, Jyonouchi, Soma, Raje, Nikita, Caldwell, Jason W., Huang, Yanping, Burkhardt, Janis K., Latour, Sylvain, Chen, Baoyu, ElGhazali, Gehad, Rao, V. Koneti, Chinn, Ivan K., Lenardo, Michael J.
Format Journal Article
LanguageEnglish
Published United States The American Association for the Advancement of Science 10.07.2020
American Association for the Advancement of Science (AAAS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The WAVE regulatory complex (WRC) is a multiunit complex that regulates actin cytoskeleton formation. Although other actin-regulatory proteins modulate human immune responses, the precise role for the WRC has not yet been established. Cook et al. studied five patients from four unrelated families who harbor missense variants of the gene encoding the WRC component HEM1. These patients presented with recurrent infections and poor antibody responses, along with enhanced allergic and autoimmune disorders. HEM1 was found to be required for the regulation of cortical actin and granule release in T cells and also interacted with a key metabolic signaling complex contributing to the disease phenotype. By linking these interactions to immune function, this work suggests potential targets for future immunotherapies. Science , this issue p. 202 A study of a hereditary disease uncovers a role for HEM1 in the simultaneous regulation of F-actin and mTORC2 signaling to balance immune responses. Immunodeficiency often coincides with hyperactive immune disorders such as autoimmunity, lymphoproliferation, or atopy, but this coincidence is rarely understood on a molecular level. We describe five patients from four families with immunodeficiency coupled with atopy, lymphoproliferation, and cytokine overproduction harboring mutations in NCKAP1L , which encodes the hematopoietic-specific HEM1 protein. These mutations cause the loss of the HEM1 protein and the WAVE regulatory complex (WRC) or disrupt binding to the WRC regulator, Arf1, thereby impairing actin polymerization, synapse formation, and immune cell migration. Diminished cortical actin networks caused by WRC loss led to uncontrolled cytokine release and immune hyperresponsiveness. HEM1 loss also blocked mechanistic target of rapamycin complex 2 (mTORC2)–dependent AKT phosphorylation, T cell proliferation, and selected effector functions, leading to immunodeficiency. Thus, the evolutionarily conserved HEM1 protein simultaneously regulates filamentous actin (F-actin) and mTORC2 signaling to achieve equipoise in immune responses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC8383235
These authors contributed equally.
Author contributions: W.A.C., S.A.C., and A.J.F. performed experiments related to WRC expression/function, T cell activation/function, NKL cell analysis, analyzed data, and interpreted results. S.A.C. performed experiments related to the functional validation of P359L, M371V, and V519L, patient cell microscopy, and RICTOR interaction studies. M.C.P., A.V.H., A.F.C., E.M.M., and J.S.O. directed or performed NK cell experiments, biochemical analysis of the mTORC2 complex, analyzed data, and interpreted results. D.B.K. performed neutrophil experiments and analyzed data. W.A.C. prepared immunoprecipitation-mass spectrometry (MS) samples and D.E.A. performed MS analysis and generated the list of interacting proteins. S.Y. performed in-vitro WRC reconstitution, pull-down and actin polymerization assays. M.S. acquired images and analyzed granule localization in patient cells. S.P., G.C., and V.K.R. oversaw care of Pt 1.1 and V.K.R., M.S., and A.O. performed and interpreted WES for Kindred 1. J.W.C., and N.R. oversaw care of Pts 2.1 and 2.2 and T.N.C., Z.H.C-A., S.N.J., D.M.M., R.A.G., and J.R.L. performed and interpreted WES to identify causal variants for kindred 2. M.A.H., N.A.K., Z.A.Y., S.J., and G.E. oversaw care of Pt 3.1, G.E. performed and G.E. and A.O. interpreted WES for kindred 3 to identify causal mutations. W.A.C. (2), B.F., and S.L. oversaw care of Pt 4.1 and performed and interpreted WES to identify causal mutations. Patient clinical histories were prepared by W.A.C., M.C.P., and attending physicians. J.S.O., L.R.F., J.K.B., S.L., B.C., G.E., V.K.R., I.K.C., and M.J.L. supervised various aspects of the project and project personnel. W.A.C., S.A.C., M.C.P., I.K.C., and M.J.L. interpreted results and wrote the manuscript. W.A.C. and S.A.C. took day-to-day responsibility for the study. M.J.L. coordinated the overall direction of the study. All authors read and provided appropriate feedback on the submitted manuscript.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.aay5663